Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 8,910.00
-170.00 (-1.87%)
Jun 12, 2026, 3:30 PM KST
Chevron Lubricants Lanka Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -21,302 | -22,128 | -6,930 | -14,499 | -15,807 | -20,051 |
Depreciation & Amortization | 1,365 | 1,306 | 633.82 | 1,435 | 1,782 | 2,703 |
Asset Writedown & Restructuring Costs | - | - | - | 4,769 | - | 7,517 |
Loss (Gain) From Sale of Investments | -137.45 | 9.04 | -14.05 | -123.67 | -910.99 | - |
Loss (Gain) on Equity Investments | 4,110 | 4,766 | 5,730 | - | -8,834 | -93.91 |
Stock-Based Compensation | 323.22 | 22.6 | -77.98 | 402.42 | 596.94 | 578.26 |
Provision & Write-off of Bad Debts | 89.74 | 89.74 | 156.13 | -28.78 | 5,260 | -583.99 |
Other Operating Activities | 328.63 | 673.67 | 2,717 | 911.44 | -79.49 | 3,925 |
Change in Accounts Receivable | -298.97 | -2,170 | 43.52 | 864.23 | 1,184 | 3,526 |
Change in Inventory | 471.04 | -161.99 | 1,374 | 358.12 | 403.6 | 864.9 |
Change in Accounts Payable | -214.24 | -57.7 | 447.9 | -256.2 | 503.57 | 13.43 |
Change in Other Net Operating Assets | -418.97 | 601.48 | -1,824 | 159.77 | -642.06 | 1,063 |
Operating Cash Flow | -15,685 | -17,050 | 2,257 | -6,008 | -16,544 | -538.48 |
Capital Expenditures | -348.59 | -1,194 | -169.57 | -539.7 | -1,544 | -3,747 |
Sale (Purchase) of Intangibles | -19,000 | -19,000 | -2,000 | -47.84 | - | -15.12 |
Investment in Securities | -16,814 | -19,836 | -16,934 | 6,000 | 10,210 | -13,010 |
Other Investing Activities | 1,131 | 1,233 | -773.14 | -557 | -0.4 | 1,773 |
Investing Cash Flow | -34,808 | -38,586 | -19,740 | 5,177 | 8,518 | -12,359 |
Long-Term Debt Issued | - | 14,845 | 20,001 | - | - | - |
Total Debt Issued | 14,832 | 14,845 | 20,001 | - | - | - |
Short-Term Debt Repaid | - | -5,000 | -400 | -500 | -500 | - |
Long-Term Debt Repaid | - | -19,386 | -116.58 | -362.88 | -1,194 | -1,246 |
Total Debt Repaid | -19,393 | -24,386 | -516.58 | -862.88 | -1,694 | -1,246 |
Net Debt Issued (Repaid) | -4,561 | -9,541 | 19,484 | -862.88 | -1,694 | -1,246 |
Issuance of Common Stock | - | 84,258 | 139.96 | 1,094 | 3,596 | 4,449 |
Other Financing Activities | -280.71 | -344.38 | -434.78 | -289.18 | -229.04 | -209.66 |
Financing Cash Flow | -4,842 | 74,373 | 19,190 | -57.97 | 1,673 | 2,994 |
Foreign Exchange Rate Adjustments | -13.47 | -56.06 | 138.47 | -31.72 | -103.42 | -122.29 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | - | - | - |
Net Cash Flow | -55,348 | 18,681 | 1,845 | -920.54 | -6,456 | -10,026 |
Free Cash Flow | -16,034 | -18,244 | 2,087 | -6,548 | -18,087 | -4,285 |
Free Cash Flow Margin | -511.73% | -518.69% | 13.87% | -69.06% | -230.36% | -46.37% |
Free Cash Flow Per Share | -166.60 | -194.05 | 26.21 | -82.31 | -229.72 | -58.04 |
Cash Interest Paid | 280.71 | 344.38 | 434.78 | 289.18 | 222.4 | 209.66 |
Cash Income Tax Paid | 175.16 | 136.58 | -54.28 | 19.19 | -17.99 | 78.92 |
Levered Free Cash Flow | -29,289 | -31,915 | -2,581 | -4,900 | -8,388 | 1,337 |
Unlevered Free Cash Flow | -28,041 | -30,393 | -1,135 | -4,704 | -8,108 | 3,214 |
Change in Working Capital | -461.14 | -1,788 | 41.17 | 1,126 | 1,449 | 5,467 |